Manuel Mattheisen

Effects of BDNF Val 66 Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • J. I. Schweiger, University Medical Centre Mannheim
  • ,
  • E. Bilek, University Medical Centre Mannheim
  • ,
  • A. Schäfer, University Medical Centre Mannheim
  • ,
  • U. Braun, University Medical Centre Mannheim
  • ,
  • C. Moessnang, University Medical Centre Mannheim
  • ,
  • A. Harneit, University Medical Centre Mannheim
  • ,
  • P. Post, University Medical Centre Mannheim
  • ,
  • K. Otto, University Medical Centre Mannheim
  • ,
  • N. Romanczuk-Seiferth, Charite - Universitatsmedizin Berlin
  • ,
  • S. Erk, Charite - Universitatsmedizin Berlin
  • ,
  • C. Wackerhagen, Charite - Universitatsmedizin Berlin
  • ,
  • M. Mattheisen
  • T. W. Mühleisen, Forschungszentrum Jülich (FZJ), University Hospital and University of Basel
  • ,
  • S. Cichon, Forschungszentrum Jülich (FZJ), F. Hoffmann-La Roche
  • ,
  • M. M. Nöthen, University Hospital Bonn, University of Bonn
  • ,
  • J. Frank, Department of Genetic Epidemiology in Psychiatry, University Medical Centre Mannheim
  • ,
  • S. H. Witt, University Medical Centre Mannheim
  • ,
  • M. Rietschel, University Medical Centre Mannheim
  • ,
  • A. Heinz, Charite - Universitatsmedizin Berlin
  • ,
  • H. Walter, Charite - Universitatsmedizin Berlin
  • ,
  • A. Meyer-Lindenberg, University Medical Centre Mannheim
  • ,
  • H. Tost, University Medical Centre Mannheim

Cognitive control represents an essential neuropsychological characteristic that allows for the rapid adaption of a changing environment by constant re-allocation of cognitive resources. This finely tuned mechanism is impaired in psychiatric disorders such as schizophrenia and contributes to cognitive deficits. Neuroimaging has highlighted the contribution of the anterior cingulate cortex (ACC) and prefrontal regions (PFC) on cognitive control and demonstrated the impact of genetic variation, as well as genetic liability for schizophrenia. In this study, we aimed to examine the influence of the functional single-nucleotide polymorphism (SNP) rs6265 of a plasticity-related neurotrophic factor gene, BDNF (Val 66 Met), on cognitive control. Strong evidence implicates BDNF Val 66 Met in neural plasticity in humans. Furthermore, several studies suggest that although the variant is not convincingly associated with schizophrenia risk, it seems to be a modifier of the clinical presentation and course of the disease. In order to clarify the underlying mechanisms using functional magnetic resonance imaging (fMRI), we studied the effects of this SNP on ACC and PFC activation, and the connectivity between these regions in a discovery sample of 85 healthy individuals and sought to replicate this effect in an independent sample of 253 individuals. Additionally, we tested the identified imaging phenotype in relation to schizophrenia familial risk in a sample of 58 unaffected first-degree relatives of schizophrenia patients. We found a significant increase in interregional connectivity between ACC and PFC in the risk-associated BDNF 66 Met allele carriers. Furthermore, we replicated this effect in an independent sample and demonstrated its independence of structural confounds, as well as task specificity. A similar coupling increase was detectable in individuals with increased familial risk for schizophrenia. Our results show that a key neural circuit for cognitive control is influenced by a plasticity-related genetic variant, which may render this circuit particular susceptible to genetic and environmental risk factors for schizophrenia.

Original languageEnglish
JournalNeuropsychopharmacology
Volume44
Issue3
Pages (from-to)590-597
Number of pages8
ISSN0893-133X
DOIs
Publication statusPublished - Feb 2019

See relations at Aarhus University Citationformats

ID: 150086301